| 13.17 Data as of May 24 | +0.46 / +3.62%Today’s Change | 6.25 Today|||52-Week Range 13.23 | +76.07% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $848.2M |
Company Description
Neurocrine Biosciences, Inc. operates as a product based biopharmaceutical company, which discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Its product candidates address endometriosis, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Employees

Shareholders
| Mutual fund holders | 49.16% |
| Other institutional | 37.84% |
| Individual stakeholders | 11.03% |
Top Executives
| Kevin C. Gorman, PhD, MBA | President, Chief Executive Officer & Director |
| Bill Wilson | Vice President-Information Technology & Operations |
| Timothy P. Coughlin, CPA | Chief Financial Officer |
| Haig P. Bozigian, PhD | Chief Development Officer |
| Dimitri E. Grigoriadis, PhD | Chief Research Officer |